Back
Day Range
$8.96
$9.24
52-Week Range
$8.72
$15.55
Volume
1,080,973
50D / 200D Avg
$10.51
/
$12.02
Prev Close
$8.89
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 5.6 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 8.8 | 3.8 |
| Rev Growth 5Y % | -1.9 | 10.0 |
| D/E | — | 0.2 |
Key Takeaways
Revenue declined -1.87% annually over 5 years
Earnings grew 21.84% over the past year
Generating 182.40M in free cash flow
P/E of 5.61 — trading at a low valuation
PEG of 0.42 suggests growth is underpriced
Cash machine — converts 191.19% of earnings into free cash flow
Growth
Revenue Growth (5Y)
-1.87%
Revenue (1Y)-3.80%
Earnings (1Y)21.84%
FCF Growth (3Y)110.41%
Quality
Return on Equity
N/A
ROIC31.68%
Net Margin8.83%
Op. Margin30.48%
Safety
Debt / Equity
N/A
Current Ratio2.41
Interest Coverage3.07
Valuation
P/E Ratio
5.61
P/B RatioN/A
EV/EBITDA5.28
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.80% | Revenue Growth (3Y) | -1.82% |
| Earnings Growth (1Y) | 21.84% | Earnings Growth (3Y) | 16.41% |
| Revenue Growth (5Y) | -1.87% | Earnings Growth (5Y) | -30.75% |
| Profitability | |||
| Revenue (TTM) | 1.08B | Net Income (TTM) | 95.40M |
| ROE | N/A | ROA | 8.75% |
| Gross Margin | 62.89% | Operating Margin | 30.48% |
| Net Margin | 8.83% | Free Cash Flow (TTM) | 182.40M |
| ROIC | 31.68% | FCF Growth (3Y) | 110.41% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.41 |
| Interest Coverage | 3.07 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 5.61 | P/B Ratio | N/A |
| P/S Ratio | 0.49 | PEG Ratio | 0.42 |
| EV/EBITDA | 5.28 | Dividend Yield | 0.04% |
| Market Cap | 534.76M | Enterprise Value | 1.74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.08B | 1.12B | 1.12B | 1.13B | 1.17B |
| Net Income | 95.40M | 78.30M | 70.40M | 223.60M | 414.80M |
| EPS (Diluted) | 1.62 | 1.34 | 1.22 | 3.89 | 7.31 |
| Gross Profit | 679.50M | 728.90M | 749.90M | 774.90M | 800.00M |
| Operating Income | 329.30M | 174.20M | 229.60M | 378.10M | 492.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.09B | 1.29B | 1.21B | 1.09B | 788.00M |
| Total Liabilities | 1.74B | 2.02B | 2.04B | 1.98B | 194.00M |
| Shareholders' Equity | -650.60M | -738.30M | -821.70M | -891.40M | 594.00M |
| Total Debt | 1.43B | 1.61B | 1.64B | 1.64B | 0.0 |
| Cash & Equivalents | 225.50M | 267.50M | 326.30M | 330.90M | 0.0 |
| Current Assets | 631.40M | 761.00M | 749.10M | 664.70M | 292.00M |
| Current Liabilities | 261.50M | 374.00M | 353.50M | 301.00M | 164.00M |